Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones

López‐Fernández, Teresa; Martín-García, Ana; Beltrán, Ana Santaballa; Montero, Á.; Sanz, Ramón Garcí­a; Ramos, Pilar Mazón; Castillo, Sonia Velasco del; Areses, Esteban López de Sá y; Barreiro-Pérez, Manuel; Baydes, R Hinojar; Isla, Leopoldo Pérez de; López, Silvia; Dalmau, Regina; Calvo-Iglesias, Francisco; Ferrer, Juan José González; Fernández, Antonio; González-Caballero, Eva; Mitroi, Cristina; Arenas, Meritxell; Echaburu, Juan Antonio Virizuela; Marco, Pascual; Romo, Andrés Íñiguez; Zamorano, José Luís; Gómez, Juan Carlos Plana; Henchel, José Luis López Sendón

doi:10.1016/j.recesp.2016.12.021

Cited by 80 publications

(79 citation statements)

References 80 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We also need to clarify the time when to start the prevention of cardiotoxicity to have the greatest benefits and to fill gaps in the study of multiple chronic conditions. We hope that researchers will recognize that multidisciplinary cooperation is a necessary condition for the development of cardio-oncology [15,30,31].…”

Section: Discussionmentioning

confidence: 99%

Bibliometric Analysis of the Results of Cardio‐Oncology Research

Wei

Liao

Chang

et al. 2020

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Objective. To analyze the development of cardio-oncology, summarize the research achievements, and provide proposals for its future research. Methods. The web of science database was used to search for “cardio-oncology” and “oncocardiology” related articles from the beginning of the database (1970) to April 5, 2019. Excel 2016 and Cytoscape were used to analyze the trend of cardio-oncology research. Results. A total of 356 articles were obtained. The number of articles has grown rapidly in recent years. Cardiac injury caused by tumor therapy was a research hotspot (n = 107). Researchers paid more attention to the prevention and treatment of cardiotoxicity (n = 54). Experimental researches were a small part of all studies (n = 72), mainly focusing on the study of cancer drugs’ cardiac injury, test indicators of cardiotoxicity, and preventive drugs. The United States (n = 156.25), Italy (n = 48.5), and Canada (n = 23.5) published the most articles, making a great contribution to the development of cardio-oncology. Conclusions. Cardio-oncology has been developing rapidly and receiving a large amount of research efforts in recent years. Most articles on cardio-oncology were published by the authors from the United States (44%) and Italy (17%), while other countries need to pay more attention to cardio-oncology. As an independent discipline, cardio-oncology is certainly in need of significant progress, but it has formed a basic framework, which has obtained many leading theories and meaningful achievements in diagnostic criteria, diagnostic methods, prevention and treatment, mechanism research, and influencing factor. Cardiac injury of tumor drugs has always been a research hotspot in this discipline, and there is still a lot of research space. The research about detection methods of cardiotoxicity and preventive drugs is gradually increasing. Basic research lags behind, and many mechanisms are still unclear.

show abstract

Section: Discussionmentioning

confidence: 99%

Bibliometric Analysis of the Results of Cardio‐Oncology Research

Wei

Liao

Chang

et al. 2020

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

show abstract

“…Los avances en la detección precoz y los tratamientos del cáncer han reducido significativamente la mortalidad asociada a este diagnóstico, haciendo más importante tanto el seguimiento a medio-largo plazo de los pacientes, como la promoción de su adaptación a unas condiciones de salud que, en ocasiones, son crónicas (35) . Este hecho, junto al reconocimiento de la importancia de individualizar el tratamiento psicológico para cada paciente, promovió el desarrollo de instrumentos de evaluación como el CMAE-OH de Arranz y Ulla (20) .…”

Section: Conclusionesunclassified

Validación de un Cuestionario Multidimensional de Adaptación a la Enfermedad para Pacientes Renales en Diálisis (CMAE-RD) diseñado a partir de un cuestionario para pacientes oncohematológicos

Rodríguez-Rey

García-Llana

Górriz

et al. 2020

PSIC

View full text Add to dashboard Cite

Objetivos: El objetivo de este trabajo es estudiar las propiedades psicométricas de un cuestionario multidimensional de adaptación a la enfermedad para pacientes con enfermedad renal en diálisis (CMAE-RD). Métodos: Esta herramienta está diseñada para ser administrada por un profesional de la psicología en forma de entrevista semiestructurada y fue diseñado a partir de un cuestionario previo para pacientes oncohematológicos. Un total de 113 pacientes en hemodiálisis fueron entrevistados mediante el CMAE-RD y completaron dos cuestionarios adicionales con propósitos de validación: el HADS (para evaluar ansiedad y depresión) y el CDRISC-2 (para evaluar resiliencia). Resultados: La consistencia interna para las áreas del CMAE-RD estuvo comprendida entre 0,53 y 0,70, y se obtuvieron evidencias de validez relacionada con un criterio externo y concurrente especialmente para las áreas que evaluaban el grado en que el paciente está informado y su estado de ánimo. Conclusiones: CMAE-RD presenta niveles adecuados de fiabilidad y validez, siendo una herramienta útil desde el punto de vista clínico, pues permite evaluar las necesidades y recursos de los pacientes, guiando la intervención psicológica.

show abstract

“…Optimization of CV risk factors and previous CV conditions is mandatory, as well as a structured advice regarding a healthy lifestyle (diet, smoking and exercise). CV risk stratification with the EAPC’S HeartScore (https://heartscore.escardio.org/2012/calc.aspx?model=europelow) helps to define specific therapeutic goals for CV risk factors’ control (Table 1) [3, 4, 9]. Baseline echocardiography, in patients at risk for heart failure (HF), helps to optimize CV therapy and to define individuals requiring a close supervision during therapy [10].…”

Section: Preventive Strategiesmentioning

confidence: 99%

“…We define cardiotoxicity as any cancer treatment-related CV event. Diagnostic criteria are similar to those used for general population, with the exception of cardiac dysfunction due to antitumor medication that is defined as a decrease in left ventricular ejection fraction (LVEF) > 10% from baseline to a final LVEF below the lower limit of normal (< 53%) [4, 16]. Table 2 summarizes the most common CV side effects of anticancer therapies [17].…”

Section: Monitoring and Diagnosis Of Cardiotoxicitymentioning

confidence: 99%

“…Baseline values are needed to evaluate significant changes during follow-up.Imaging techniques: echocardiography is deemed the technique of choice when undertaking a global comprehensive assessment of cardiac structure and function at baseline and during the cancer process. In patients with poor image quality, cardiac magnetic resonance is the best option to avoid the radiation associated with nuclear medicine techniques [3, 4, 16]. Monitoring protocols during treatment should be adapted to both the availability of local resources and the professionals’ expertise [3, 4] to avoid unjustified delays in cancer treatment.…”

Section: Monitoring and Diagnosis Of Cardiotoxicitymentioning

confidence: 99%

See 1 more Smart Citation

SEOM clinical guidelines on cardiovascular toxicity (2018)

et al. 2019

View full text Add to dashboard Cite

One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor’s prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM’s ongoing commitment to progressing and improving supportive care for cancer patients.

show abstract

Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones

Cited by 80 publications

References 80 publications

Bibliometric Analysis of the Results of Cardio‐Oncology Research

Bibliometric Analysis of the Results of Cardio‐Oncology Research

Validación de un Cuestionario Multidimensional de Adaptación a la Enfermedad para Pacientes Renales en Diálisis (CMAE-RD) diseñado a partir de un cuestionario para pacientes oncohematológicos

SEOM clinical guidelines on cardiovascular toxicity (2018)

Contact Info

Product

Resources

About